세계의 제세동기 시장 : 유형별, 최종 사용자별, 환자 유형별 예측(2025-2030년)

The Defibrillators Market was valued at USD 14.07 billion in 2023, expected to reach USD 14.96 billion in 2024, and is projected to grow at a CAGR of 6.77%, to USD 22.27 billion by 2030.

The defibrillator market encompasses a range of medical devices used to restore a normal heartbeat by sending an electric pulse or shock to the heart. These devices are crucial in treating life-threatening cardiac dysrhythmias, ventricular fibrillation, and pulseless ventricular tachycardia. Necessity arises primarily from the global rise in cardiovascular diseases and the increasing prevalence of sudden cardiac arrests, making them vital in emergency responses and public spaces, hospitals, and homes. The application scope extends across various forms of defibrillators, including Automated External Defibrillators (AEDs), implanted defibrillators, and wearable defibrillators, catering to different end users such as hospitals, pre-hospital settings, ambulances, and households.

Market growth is influenced by factors like technological advancements, the aging population, increased public awareness, and favorable governmental policies promoting AED deployment. Opportunities abound in emerging markets with low defibrillator penetration, advancements in AI and machine learning for better predictive analytics, and emerging trends in portable and wearable defibrillator technologies. Recommendations to capture these opportunities include expanding product offerings through R&D, especially in wearable technologies, and strategic partnerships for distribution in untapped regions.

However, growth is challenged by high device costs, stringent regulatory approval processes, and lack of awareness in underdeveloped regions. Innovative opportunities lie in developing cost-effective models, enhancing connectivity for real-time monitoring, and integrating defibrillators with telehealth platforms to improve accessibility and response times. The market's nature continues to evolve with a shift towards user-friendly, smart devices that empower both medical professionals and laypersons. In essence, the defibrillator market is a dynamic and essential component of the medical devices industry, constantly innovating to meet the growing health needs globally, with a focus on reducing costs and improving technological integration to enhance overall patient outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Defibrillators Market

The Defibrillators Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Surging incidences of cardiac disorders
  • Rising availability of defibrillators in public places coupled with training and awareness programs
  • Favorable supportive regulations for increased adoption of defibrillators
• Market Restraints
  • Concerns pertinent to application of implantable and automated external defibrillators
• Market Opportunities
  • Ongoing development of S-ICDs and MRI-compatible and CRT-Ds
  • Emerging demand for automated external defibrillators in prehospital environment
• Market Challenges
  • Failure or frequent product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Defibrillators Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Defibrillators Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Defibrillators Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Defibrillators Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Defibrillators Market

A detailed market share analysis in the Defibrillators Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Defibrillators Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Defibrillators Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Defibrillators Market

A strategic analysis of the Defibrillators Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Defibrillators Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMI Italia S.r.l., Axion Ltd., Baxter International Inc., Bexen Cardio By Osatu S Coop, Biotronik SE & CoKG, Boston Scientific Corporation, CU Medical Systems, Inc., GE Healthcare, Koninklijke Philips N.V., LivaNova PLC, Mediana Co., Ltd., Medtonic PLC, Metsis Medikal, MicroPort Scientific Corporation, Narang Medical Limited, Nihon Kohden Corporation, Olympus Corporation, Progetti Srl, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Stryker Corporation, Thermo Fisher Scientific Inc., and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Defibrillators Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across External Defibrillators and Implantable Cardioverter Defibrillators. The Implantable Cardioverter Defibrillators is further studied across Subcutaneous Implantable Cardioverter Defibrillators and TransvenoSubcutaneous Implantable Cardioverter Defibrillators. The TransvenoSubcutaneous Implantable Cardioverter Defibrillators is further studied across Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators, Dual-Chamber ICDs, and Single-Chamber ICDs.
• Based on End-User, market is studied across Alternate Care Facilities, Home Care Settings, Hospitals, Clinics, & Cardiac Centers, and Prehospital Care Settings.
• Based on Patient Type, market is studied across Adult and Pediatric.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Surging incidences of cardiac disorders
    • 5.1.1.2. Rising availability of defibrillators in public places coupled with training and awareness programs
    • 5.1.1.3. Favorable supportive regulations for increased adoption of defibrillators
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns pertinent to application of implantable and automated external defibrillators
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing development of S-ICDs and MRI-compatible and CRT-Ds
    • 5.1.3.2. Emerging demand for automated external defibrillators in prehospital environment
  • 5.1.4. Challenges
    • 5.1.4.1. Failure or frequent product recalls
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Defibrillators Market, by Type

• 6.1. Introduction
• 6.2. External Defibrillators
• 6.3. Implantable Cardioverter Defibrillators
  • 6.3.1. Subcutaneous Implantable Cardioverter Defibrillators
  • 6.3.2. TransvenoSubcutaneous Implantable Cardioverter Defibrillators
    • 6.3.2.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators
    • 6.3.2.2. Dual-Chamber ICDs
    • 6.3.2.3. Single-Chamber ICDs

7. Defibrillators Market, by End-User

• 7.1. Introduction
• 7.2. Alternate Care Facilities
• 7.3. Home Care Settings
• 7.4. Hospitals, Clinics, & Cardiac Centers
• 7.5. Prehospital Care Settings

8. Defibrillators Market, by Patient Type

• 8.1. Introduction
• 8.2. Adult
• 8.3. Pediatric

9. Americas Defibrillators Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Defibrillators Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Defibrillators Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AMI Italia S.r.l.
• 3. Axion Ltd.
• 4. Baxter International Inc.
• 5. Bexen Cardio By Osatu S Coop
• 6. Biotronik SE & CoKG
• 7. Boston Scientific Corporation
• 8. CU Medical Systems, Inc.
• 9. GE Healthcare
• 10. Koninklijke Philips N.V.
• 11. LivaNova PLC
• 12. Mediana Co., Ltd.
• 13. Medtonic PLC
• 14. Metsis Medikal
• 15. MicroPort Scientific Corporation
• 16. Narang Medical Limited
• 17. Nihon Kohden Corporation
• 18. Olympus Corporation
• 19. Progetti Srl
• 20. Schiller AG
• 21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 22. Stryker Corporation
• 23. Thermo Fisher Scientific Inc.
• 24. ZOLL Medical Corporation